•  
  •  
 

Abstract

For both the initial evaluation and follow-up in suspected COVID-19 cases, chest CT is strongly recommended. Additionally, the disease and its severity might be suspected using basic laboratory investigations. Better clinical results and appropriate management may result from all of this. Aim to evaluate the relation between the clinical outcome of COVID-19 patients, laboratory data, and the severity of CT chest findings. Methods 90 individuals who were referred to the radiodiagnosis department from the National Hepatology and Tropical Medicine Research Institute's Internal Medicine Department after PCR confirmed that they had COVID-19 were included in this retrospective study. Each patient was subjected to complete history taking, routine laboratory investigations including PCR, CT chest without contrast is done at day 0, day 10 and day 21, correlated the CT findings with their laboratory and clinical data. Results The mean age of the studied group was 48.94 ± 14.36 years, regarding gender 58.9% of the studied group were females. The studied group had patchy shape in CT scan, 100% of the had GGO, 70% had smooth IL septal thickening, 56.7% had lymph nodes, 45.6% had consolidation, 25.6% of the studied group had nodules, 6.7% of them had pleural effusion and only 4.4% of them had cavitation. The study showed a correlation between the clinical outcomes, laboratory investigations of COVID-19 patients and CT chest results. Conclusion When estimating the outcome of SARS-CoV-2 patients, a CT chest scan can be useful in assessing the degree and severity of the disease. These results are correlated with laboratory results.

Article Type

Original Study

Subject Area

Radiology

IRB Number

12343#2022

Creative Commons License

Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.

Download

Share

COinS